CytomX Therapeutics (CTMX) Earnings Date & Reports

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CTMX is expected to report earnings to fall 71.59% to 6 cents per share on May 07

CytomX Therapeutics CTMX Stock Earnings Reports

Q1'25

Est.

$0.06

Q4'24

Beat

by $0.43

Q3'24

Beat

by $0.24

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.25

The last earnings report on March 06 showed earnings per share of 21 cents, beating the estimate of -20 cents. With 1.50M shares outstanding, the current market capitalization sits at 40.06M.

View a ticker or compare two or three

Compare

CTMX